Tirzepatide is a highly purified, synthetic dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Provided in a 50mg formulation, this peptide is engineered for advanced laboratory research focusing on metabolic pathways, glycemic regulation mechanisms, and receptor binding efficacy.
Product Specifications:
Agent: Tirzepatide
Mechanism: Dual GIP and GLP-1 receptor agonist
Quantity: 50mg
Format: Lyophilized powder
Application: Intended strictly for in-vitro research and laboratory study. Not for human consumption.